c 10

Norchlorcyclizine (C-10) is a partially selective NPR-B inhibitor. It also is an inhibitor of human tyrosyl-DNA phosphodiesterase 1.

Biotin-C10-NHS Ester, an alkyl/ether-based linker compound, is utilized in the synthesis of PROTACs[1].

(S,R,S)-AHPC-C10-NH2 (VH032-C10-NH2) is a synthesized E3 ligase ligand-linker conjugate, comprising an (S,R,S)-AHPC-based VHL ligand and a linker, designed for BET-targeted PROTAC applications.

(S,R,S)-AHPC-C10-NH2 dihydrochloride (VH032-linker 10) is a synthesized E3 ligase ligand-linker conjugate, incorporating an (S,R,S)-AHPC-based VHL ligand and a linker[1].

(S,R,S)-AHPC-Me-C10-Br is a chemically synthesized conjugate and ligand-linker for E3 ligase, consisting of MS432 for MEK1/2 inhibitors and a VHL E3 ligase linker.

(S,R,S)-AHPC-Me-C10-NH2 is a synthesized chemical compound incorporating a VHL ligand and a linker, serving as an E3 ligase ligand-linker conjugate. It is utilized in PROTAC MS432[1].

(S,R,S)-AHPC-Me-C10-NH2 hydrochloride is a synthesized E3 ligase ligand-linker conjugate incorporating a VHL ligand and a linker.

Thalidomide-NH-C10-COOH (compound 6b) is a synthetic E3 ligase ligand-linker conjugate, combining the Thalidomide-based von Hippel-Lindau (VHL) ligand with a linker commonly used in PROTAC technology. [1]

Thiol-C10-amide-PEG8, a PEG-based linker for PROTACs, joins two essential ligands critical for forming PROTAC molecules, enabling selective protein degradation by leveraging the ubiquitin-proteasome system within cells.

Thalidomide-O-C10-NH2 is a synthetic E3 ligase ligand-linker conjugate combining a cereblon ligand derived from Thalidomide with a linker crucial for PROTAC technology.

Bromo-C10-OBn, a PROTAC linker, is utilized in the synthesis of PROTACs.

Maleimide-C10-NHS ester is an alkyl/ether-based linker utilized in PROTAC synthesis.

m-PEG8-C10-phosphonic acid is a PEG-based linker for PROTACs that joins two essential ligands, enabling selective protein degradation via the ubiquitin-proteasome system within cells [PROTACs].

Thalidomide-NH-C10-Boc (compound S20) serves as a conjugate that combines the E3 ubiquitinase ligand Thalidomide with a PROTAC Linker, enabling the recruitment of Cereblon ubiquitinase. This compound facilitates the coupling of target protein ligands via the PROTAC Linker to create PROTAC molecules capable of inducing degradation. An instance of its function includes the coupling with EP300/CBP ligand 2 to form the PROTAC molecule dCE-2.

MS1262-C3-amide-C10-amine is an E3 Ligase Ligand-Linker conjugate. It includes a GLP ligand targeting the E3 ligase SPOP and a PROTAC linker. This compound can be utilized in designing PROTACs such as example [MS479].

Boc-C3-amide-C10-amine is a PROTAC linker utilized in the synthesis of PROTACMS479.

m-PEG8-amide-C10-Thiol is a PROTAC linker that falls under the PEG category and is utilized for synthesizing PROTAC molecules.

(S,R,S)-AHPC-amide-C10-azide is an E3 ubiquitin ligase VHL ligand utilized for recruiting VHL protein. This compound can be linked to a target protein ligand via a linker to form a PROTAC.

Mal-C2-amide-C10-tri-GalNAc (Compound 1226) serves as a binding ligand fragment for the asialoglycoprotein receptor (ASGPR) and constitutes part of lysosome-targeting bifunctional molecules. It facilitates the sequestration and degradation of extracellular target molecules within lysosomes and is applicable in autoimmune disease research.

Thalidomide-4-O-C10-Br is an E3 ligase ligand-linker conjugate, consisting of a Thalidomide-based CRBN ligand and a linker. It is capable of connecting with a protein ligand through the linker to form PROTACEZH2 Degrader-22.

6BrCaQ-C10-TPP, a potent inhibitor of the mitochondrial heat shock protein TRAP1, exhibits antiproliferative activity against various human cancer cells, with an IC50 range of 0.008-0.30 μM. Additionally, it induces disturbances in mitochondrial membranes [1].

Thalidomide-4-O-C10-NH2 hydrochloride, a Thalidomide-based cereblon ligand, facilitates the recruitment of the CRBN protein. This compound can be conjugated with a protein ligand via a linker to synthesize PROTACs [1].

Thalidomide-5-O-C10-NH2 hydrochloride, a Thalidomide-based cereblon ligand, facilitates the recruitment of CRBN protein and, when linked to a protein ligand, forms PROTACs [1].

Pomalidomide-5-C10-NH2 hydrochloride, a Pomalidomide-derived cereblon (CRBN) ligand, facilitates the recruitment of CRBN protein. This compound can be tethered to a protein ligand via a linker to construct a PROTAC [1].